YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Intracranial Plasmacytomas

dc.authorscopusid 55984682600
dc.authorscopusid 7003549565
dc.authorscopusid 7003281816
dc.contributor.author Cirak, B.
dc.contributor.author Inci, S.
dc.contributor.author Palaoglu, S.
dc.date.accessioned 2025-05-10T17:50:51Z
dc.date.available 2025-05-10T17:50:51Z
dc.date.issued 1999
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Cirak B., Yuzuncuyil University, Faculty of Medicine, Department of Neurosurgery, Van, Turkey; Inci S., Yuzuncuyil University, Faculty of Medicine, Department of Neurosurgery, Van, Turkey; Palaoglu S., Yuzuncuyil University, Faculty of Medicine, Department of Neurosurgery, Van, Turkey en_US
dc.description.abstract Background: Solitary plasmacytoma of the central nervous system is a rarely reported pathology in the literature, and mostly are in the form of case reports. We retrospectively evaluated six cases of intracranial plasmacytoma. Method: Six patients' files were evaluated retrospectively. Their presenting symtomps and signs, laboratory and radiological findings, surgical intervention, adjuvant treatment protocols and outcomes were analysed. Results: All six patients were diagnosed clinically, radiologically and histologically as solitary intracranial plasmacytoma. All of the patients underwent radiotherapy regardless of the extensivity of the surgical resection. Two patients whose tumors were resected subtotally were put on chemotherapy postoperatively. Of these six patients, three died in the follow up period with the diagnosis of dissemination into the multiple myeloma, three patients had a good outcome. Conclusion: Intracranial solitary plasmacytoma, eventhough, is a rare pathology, may be mortal if it is not properly handled. Total resection it must be the aim of surgery. Radiotherapy, and in partially resected cases, chemotherapy as adjuvant are helpful. Although everykind of treatment regiment has been applied, change into multiple myeloma may occur in follow up period. en_US
dc.identifier.endpage 124 en_US
dc.identifier.issn 1300-0683
dc.identifier.issue 2 en_US
dc.identifier.scopus 2-s2.0-0033390279
dc.identifier.scopusquality N/A
dc.identifier.startpage 122 en_US
dc.identifier.uri https://hdl.handle.net/20.500.14720/17882
dc.identifier.volume 8 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.relation.ispartof Annals of Medical Sciences en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Intracranial Plasmacytoma en_US
dc.subject Multiple Myeloma en_US
dc.subject Surgery en_US
dc.title Intracranial Plasmacytomas en_US
dc.type Article en_US

Files